Lowe's Companies, Inc. · LOW · FY2026 Q3 · Calendar Q4 2026
Lowe’s raises FY2026 sales outlook as Pro, digital and services demand support Q3
The supplied Q3 analysis points to firmer sales momentum than in the prior quarter, supported by Pro, online and home-services demand. Whether that progress translates into durable earnings growth depends on margins, cost pressures and acquisition execution.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about LOW FY2026 Q3
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, management’s outlook shifted from a lower-end full-year sales view to a raised $92.5 billion sales outlook. The Q3 analysis also describes 9.3% year-over-year sales growth and 1.8% comparable-sales growth, while identifying fuel costs and category mix as margin considerations.
Guidance delta
Raised FY2026 sales outlook to $92.5 billion; the supplied analysis lists EPS guidance of $12.25 and adjusted operating-margin guidance of 11.5%.
Key takeaways
- Q3 sales rose 9.3% year over year, with comparable sales up 1.8%, according to the supplied transcript analysis.
- Pro, online sales and appliances were identified as important sources of demand; online sales grew 17.4%.
- Management raised its FY2026 sales outlook and highlighted home-services demand and acquisition integration.
- Fuel and transportation costs and a mix shift toward lower-margin categories temper the topline picture.
Management priorities
- Expand Pro reach and customer loyalty, including same-day fulfillment.
- Continue investment in e-commerce, loyalty, fulfillment and MyLow AI tools.
- Integrate FBM and ADG and expand FBM’s footprint.
- Execute holiday promotions and provide further Total Home Strategy and marketplace detail at the December investor conference.
Follow LOW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Outperform | Outperform | Maintain | Nov 10, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Nov 9, 2026 |
| Stifel | Hold | Hold | Maintain | Oct 26, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 20, 2026 |
| Guggenheim | Buy | Buy | Maintain | Sep 21, 2026 |
| UBS | Buy | Buy | Maintain | Aug 20, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 20, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | Aug 20, 2026 |
| TD Cowen | Hold | Hold | Maintain | Aug 20, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 20, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Aug 20, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 20, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Aug 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 20, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 11, 2026 |
| Baird | Outperform | Outperform | Maintain | May 21, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | May 21, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | May 18, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 15, 2026 |
| Gordon Haskett | Buy | Hold | Upgrade | Jan 13, 2026 |
| Barclays | Overweight | Equal Weight | Upgrade | Jan 7, 2026 |
| Wedbush | Neutral | Neutral | Maintain | Dec 12, 2024 |
| Loop Capital | Buy | Hold | Upgrade | Oct 9, 2024 |
| Zelman & Assoc | Neutral | Outperform | Downgrade | Apr 2, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 13, 2024 |
| Argus Research | Buy | Buy | Maintain | Jul 12, 2023 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Oct 19, 2022 |
| R5 Capital | Hold | Buy | Downgrade | Oct 10, 2022 |
| Jefferies | Buy | Buy | Maintain | Oct 3, 2022 |
| MKM Partners | Neutral | Neutral | Maintain | Aug 18, 2022 |
| OTR Global | Mixed | Positive | Downgrade | May 10, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 19, 2021 |
| Zelman | Hold | Buy | Downgrade | Apr 15, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Apr 14, 2021 |
| Nomura Instinet | Buy | Buy | Maintain | Jun 23, 2020 |
| Nomura | Buy | Buy | Maintain | Jun 23, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 21, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 27, 2020 |
| Piper Jaffray | Overweight | Neutral | Upgrade | Oct 15, 2019 |
| Raymond James | Market Perform | Outperform | Downgrade | Oct 8, 2019 |
| Citi | Buy | Buy | Maintain | Sep 13, 2019 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 21, 2018 |
| Bank of America | Buy | Buy | Maintain | Aug 23, 2018 |
| Argus | Buy | Buy | Maintain | May 25, 2018 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 2, 2018 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 1, 2018 |
| Cleveland Research | Neutral | Buy | Downgrade | Oct 6, 2016 |
| Canaccord Genuity | Hold | Sell | Upgrade | Nov 19, 2014 |
| ISI Group | Buy | Neutral | Upgrade | May 8, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $220.84. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Scot Ciccarelli | $240 | $219.62 | +8.7% | Nov 19, 2026 |
| Mizuho Securities | David Bellinger | $248 | $222.72 | +12.3% | Nov 19, 2026 |
| Truist Financial | Scot Ciccarelli | $254 | $220.44 | +15.0% | Nov 18, 2026 |
| Bernstein | Zhihan Ma | $270 | $229.36 | +22.3% | Nov 10, 2026 |
| Stifel Nicolaus | Andrew Carter | $195 | $198.68 | -11.7% | Oct 26, 2026 |
| Evercore ISI | Analyst unavailable | $190 | $181.2 | -14.0% | Oct 6, 2026 |
| Melius Research | Analyst unavailable | $244 | $181.39 | +10.5% | Oct 6, 2026 |
| Gordon Haskett Capital Corporation | Analyst unavailable | $200 | $189.8 | -9.4% | Sep 24, 2026 |
| Bernstein | Zhihan Ma | $254 | $201.09 | +15.0% | Sep 9, 2026 |
| Guggenheim | Steven Forbes | $275 | $217.34 | +24.5% | Aug 21, 2026 |
| Mizuho Securities | David Bellinger | $250 | $220.71 | +13.2% | Aug 20, 2026 |
| Truist Financial | Scot Ciccarelli | $255 | $215.84 | +15.5% | May 21, 2026 |
| RBC Capital | Analyst unavailable | $232 | $216.57 | +5.1% | May 21, 2026 |
| Piper Sandler | Peter Keith | $276 | $215.96 | +25.0% | May 21, 2026 |
| Wolfe Research | Analyst unavailable | $254 | $221.1 | +15.0% | May 21, 2026 |
| Wells Fargo | Zachary Fadem | $255 | $221.1 | +15.5% | May 21, 2026 |
| Truist Financial | Scot Ciccarelli | $280 | $217.45 | +26.8% | May 20, 2026 |
| D.A. Davidson | Michael Baker | $275 | $262.54 | +24.5% | Feb 26, 2026 |
| Jefferies | Jonathan Matuszewski | $305 | $263.02 | +38.1% | Feb 25, 2026 |
| RBC Capital | Steven Shemesh | $257 | $277.09 | +16.4% | Feb 23, 2026 |
| Bernstein | Analyst unavailable | $313 | $281.16 | +41.7% | Feb 18, 2026 |
| Truist Financial | Analyst unavailable | $295 | $277.01 | +33.6% | Jan 16, 2026 |
| Morgan Stanley | Simeon Gutman | $296 | $274.95 | +34.0% | Jan 15, 2026 |
| Gordon Haskett Capital Corporation | Analyst unavailable | $325 | $270.89 | +47.2% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $285 | $246.49 | +29.1% | Jan 7, 2026 |
| Truist Financial | Scot Ciccarelli | $269 | $248.82 | +21.8% | Dec 17, 2025 |
| RBC Capital | Analyst unavailable | $252 | $229.37 | +14.1% | Nov 20, 2025 |
| D.A. Davidson | Michael Baker | $250 | $230.48 | +13.2% | Nov 20, 2025 |
| Robert W. Baird | Peter Benedict | $290 | $230.48 | +31.3% | Nov 20, 2025 |
| UBS | Analyst unavailable | $316 | $230.48 | +43.1% | Nov 20, 2025 |
| Mizuho Securities | Analyst unavailable | $272 | $230.48 | +23.2% | Nov 20, 2025 |
| Bernstein | Zhihan Ma | $284 | $230.48 | +28.6% | Nov 20, 2025 |
| Stifel Nicolaus | Andrew Carter | $230 | $228.09 | +4.1% | Nov 14, 2025 |
| Wolfe Research | Analyst unavailable | $308 | $267.95 | +39.5% | Sep 17, 2025 |
| Mizuho Securities | David Bellinger | $285 | $257.54 | +29.1% | Aug 29, 2025 |
| Barclays | Analyst unavailable | $267 | $255.65 | +20.9% | Aug 21, 2025 |
| Truist Financial | Scot Ciccarelli | $264 | $223.75 | +19.5% | May 22, 2025 |
| Mizuho Securities | David Bellinger | $280 | $223.75 | +26.8% | May 22, 2025 |
| Bernstein | Zhihan Ma | $266 | $223.75 | +20.4% | May 22, 2025 |
| Piper Sandler | Peter Keith | $269 | $232.89 | +21.8% | Mar 24, 2025 |
| Jefferies | Jonathan Matuszewski | $301 | $235.83 | +36.3% | Nov 19, 2024 |
| Stifel Nicolaus | Andrew Carter | $265 | $235.83 | +20.0% | Nov 19, 2024 |
| Truist Financial | Scot Ciccarelli | $310 | $235.83 | +40.4% | Nov 19, 2024 |
| Goldman Sachs | Kate McShane | $260 | $235.83 | +17.7% | Nov 19, 2024 |
| Stifel Nicolaus | Andrew Carter | $260 | $268.13 | +17.7% | Nov 11, 2024 |
| Telsey Advisory | Joseph Feldman | $305 | $269.18 | +38.1% | Nov 8, 2024 |
| Loop Capital Markets | Laura Champine | $300 | $273.27 | +35.8% | Oct 9, 2024 |
| Loop Capital Markets | Laura Champine | $250 | $272.64 | +13.2% | Oct 2, 2024 |
| Oppenheimer | Brian Nagel | $305 | $262.29 | +38.1% | Sep 24, 2024 |
| Piper Sandler | Peter Keith | $262 | $242.44 | +18.6% | Aug 21, 2024 |
| Guggenheim | Steven Forbes | $260 | $240.33 | +17.7% | Aug 21, 2024 |
| Robert W. Baird | Peter Benedict | $265 | $241.7 | +20.0% | Aug 21, 2024 |
| Bank of America Securities | Robert Ohmes | $275 | $240.33 | +24.5% | Aug 21, 2024 |
| J.P. Morgan | Christopher Horvers | $272 | $243.21 | +23.2% | Aug 20, 2024 |
| Robert W. Baird | Robert Ohmes | $280 | $222.48 | +26.8% | May 22, 2024 |
| Truist Financial | Scot Ciccarelli | $265 | $224.86 | +20.0% | May 22, 2024 |
| Piper Sandler | Peter Keith | $264 | $222.42 | +19.5% | May 22, 2024 |
| RBC Capital | Steven Shemesh | $246 | $222.79 | +11.4% | May 22, 2024 |
| UBS | Michael Lasser | $270 | $224.86 | +22.3% | May 22, 2024 |
| Barclays | Matthew McClintock | $229 | $224.86 | +3.7% | May 22, 2024 |
| Wells Fargo | Zachary Fadem | $290 | $224.86 | +31.3% | May 22, 2024 |
| Evercore ISI | Greg Melich | $250 | $224.86 | +13.2% | May 22, 2024 |
| Stifel Nicolaus | Andrew Carter | $250 | $224.86 | +13.2% | May 21, 2024 |
| Jefferies | Jonathan Matuszewski | $267 | $229.17 | +20.9% | May 21, 2024 |
| Loop Capital Markets | Laura Champine | $230 | $238.01 | +4.1% | Apr 5, 2024 |
| D.A. Davidson | Michael Baker | $270 | $251.42 | +22.3% | Mar 27, 2024 |
| RBC Capital | Steven Shemesh | $194 | $194.58 | -12.2% | Nov 7, 2023 |
| Stifel Nicolaus | John Baugh | $270 | $210.13 | +22.3% | Sep 22, 2023 |
| Bernstein | Dean Rosenblum | $282 | $232.51 | +27.7% | Sep 5, 2023 |
| Telsey Advisory | Joseph Feldman | $225 | $207.22 | +1.9% | May 17, 2023 |
| Barclays | Analyst unavailable | $215 | $214.73 | -2.6% | Feb 8, 2023 |
| UBS | Analyst unavailable | $250 | $197.05 | +13.2% | Jan 6, 2023 |
| Credit Suisse | Analyst unavailable | $210 | $203.17 | -4.9% | Dec 20, 2022 |
| Goldman Sachs | Kate McShane | $246 | $206.89 | +11.4% | Dec 7, 2022 |
| Bernstein | Analyst unavailable | $237 | $206.18 | +7.3% | Dec 6, 2022 |
| Telsey Advisory | Telsey Advisory Telsey Advisory | $255 | $210.27 | +15.5% | Nov 21, 2022 |
| Goldman Sachs | Analyst unavailable | $241 | $215.13 | +9.1% | Nov 17, 2022 |
| Wells Fargo | Zachary Fadem | $245 | $214.86 | +10.9% | Nov 16, 2022 |
| Jefferies | Analyst unavailable | $259 | $194.85 | +17.3% | Oct 3, 2022 |
| MKM Partners | Analyst unavailable | $220 | $216.52 | -0.4% | Aug 18, 2022 |
| Wedbush | Analyst unavailable | $225 | $216.52 | +1.9% | Aug 18, 2022 |
| Truist Financial | Analyst unavailable | $263 | $215.24 | +19.1% | Aug 18, 2022 |
| Robert W. Baird | Analyst unavailable | $235 | $215.55 | +6.4% | Aug 18, 2022 |
| Goldman Sachs | Analyst unavailable | $252 | $214.87 | +14.1% | Aug 18, 2022 |
| J.P. Morgan | Analyst unavailable | $210 | $194.45 | -4.9% | Aug 9, 2022 |
| Wells Fargo | Analyst unavailable | $220 | $187.95 | -0.4% | Aug 3, 2022 |
| Morgan Stanley | Analyst unavailable | $270 | $189.9 | +22.3% | Jul 20, 2022 |
| Wells Fargo | Zachary Fadem | $240 | $172.47 | +8.7% | Jun 18, 2022 |
| D.A. Davidson | Analyst unavailable | $240 | $189.32 | +8.7% | May 19, 2022 |
| Truist Financial | Analyst unavailable | $237 | $187.94 | +7.3% | May 19, 2022 |
| Wedbush | Analyst unavailable | $200 | $191.62 | -9.4% | May 19, 2022 |
| Jefferies | Analyst unavailable | $238 | $187.65 | +7.8% | May 19, 2022 |
| Citigroup | Steven Zaccone | $222 | $184.83 | +0.5% | May 18, 2022 |
| Telsey Advisory | Joseph Feldman | $250 | $183.82 | +13.2% | May 18, 2022 |
| Wells Fargo | Zachary Fadem | $260 | $206.66 | +17.7% | Apr 10, 2022 |
| Gordon Haskett Capital Corporation | Chuck Grom | $255 | $202.4 | +15.5% | Apr 3, 2022 |
| Robert W. Baird | Peter Benedict | $285 | $225.02 | +29.1% | Jan 23, 2022 |
| Morgan Stanley | Simeon Gutman | $280 | $238.41 | +26.8% | Jan 18, 2022 |
| Citigroup | Steven Zaccone | $292 | $238.41 | +32.2% | Jan 18, 2022 |
| Truist Financial | Scot Ciccarelli | $293 | $249.9 | +32.7% | Jan 12, 2022 |
| D.A. Davidson | Michael Baker | $292 | $255.55 | +32.2% | Dec 30, 2021 |
| Guggenheim | Steven Forbes | $300 | $252.41 | +35.8% | Dec 16, 2021 |
| Oppenheimer | Brian Nagel | $300 | $250.35 | +35.8% | Dec 6, 2021 |
| Goldman Sachs | Kate McShane | $278 | $246.57 | +25.9% | Nov 18, 2021 |
| Loop Capital Markets | Laura Champine | $240 | $246.57 | +8.7% | Nov 18, 2021 |
| Barclays | Karen Short | $280 | $246.57 | +26.8% | Nov 18, 2021 |
| UBS | Michael Lasser | $290 | $246.57 | +31.3% | Nov 18, 2021 |
| Credit Suisse | Lavesh Hemnani | $220 | $201.2 | -0.4% | Aug 19, 2021 |
| Atlantic Equities | Sam Hudson | $240 | $198.72 | +8.7% | Apr 14, 2021 |
Track every rating change on LOW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationLowe's Companies, Inc., together with its various subsidiary entities, operates as a prominent home improvement retailer serving both the United States and international markets. The company supplies a broad spectrum of items essential for construction, upkeep, renovations, and interior design projects. Its comprehensive product line encompasses major appliances, seasonal and outdoor living essentials, lawn and garden tools, timber, kitchen and bathroom fixtures, power tools, paints, custom millwork, general hardware, flooring options, plumbing components, building materials, decorative accents, lighting solutions, and electrical supplies.…
Historical context
All LOW earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ROST Ross Stores, Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.1% | -2.8% | Ross Stores: traffic-led growth lifts FY26 EPS outlook |
| WSM Williams-Sonoma, Inc. | FY2026 Q3 · Calendar Q4 2026 | 0.0% | -15.2% | Williams-Sonoma grows sales and expands margin as guidance holds |
| BABA Alibaba Group Holding Limited | FY2027 Q2 · Calendar Q4 2026 | -29.2% | -1.3% | Alibaba’s cloud growth accelerates, while export controls temper near-term outlook |
| PDD PDD Holdings Inc. | FY2026 Q3 · Calendar Q4 2026 | +13.4% | +11.0% | PDD’s Q3: Steady Revenue, Slight Income Growth Amid Heavy Investment |
| TJX The TJX Companies, Inc. | FY2027 Q3 · Calendar Q4 2026 | 0.0% | +8.0% | TJX raises FY2027 outlook as comparable sales grow, costs pressure margins |
| VIK Viking Holdings Ltd | FY2026 Q3 · Calendar Q4 2026 | -12.6% | +4.4% | Viking’s Q3 Revenue Growth Faced River Disruptions and an EPS Miss |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPFY2026 Q3 · November 16, 2026-3.0% EPS-2.5% move
Get the LOW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-18T20:16:45.688582+00:00
- FN2 earnings calendar · 2026-11-19T01:23:16.862628+00:00
- Polygon adjusted daily market bars · 2026-11-19T08:50:44.246348+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-19T08:50:44.243701+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-19. For educational purposes only; not investment advice.